C12N 5/163
One of the fusion partners being a b or a t lymphocyte
Official title: {one of the fusion partners being a B or a T lymphocyte}
C12N5/163 (One of the fusion partners being a b or a t lymphocyte) appears on 252 US grants and 252 published applications in this corpus.
Search patents in C12N- Granted patents
- 252
- Published applications
- 252
- Assignees
- 240
- Inventors
- 690
- Latest grant
- 25 Aug 2026
Filings by year
| Year | Granted patents | Published applications |
|---|---|---|
| 1983 | 1 | 0 |
| 1984 | 5 | 0 |
| 1985 | 5 | 0 |
| 1986 | 4 | 0 |
| 1987 | 8 | 0 |
| 1988 | 6 | 0 |
| 1989 | 4 | 0 |
| 1990 | 4 | 0 |
| 1991 | 5 | 0 |
| 1992 | 8 | 0 |
| 1993 | 4 | 0 |
| 1994 | 2 | 0 |
| 1995 | 2 | 0 |
| 1996 | 8 | 0 |
| 1997 | 7 | 0 |
| 1998 | 9 | 0 |
| 1999 | 4 | 0 |
| 2000 | 4 | 0 |
| 2001 | 8 | 1 |
| 2002 | 2 | 8 |
| 2003 | 3 | 6 |
| 2004 | 0 | 7 |
| 2005 | 2 | 4 |
| 2006 | 4 | 6 |
| 2007 | 2 | 11 |
| 2008 | 3 | 2 |
| 2009 | 6 | 7 |
| 2010 | 4 | 6 |
| 2011 | 1 | 8 |
| 2012 | 4 | 6 |
| 2013 | 3 | 5 |
| 2014 | 10 | 13 |
| 2015 | 10 | 13 |
| 2016 | 13 | 17 |
| 2017 | 10 | 17 |
| 2018 | 11 | 15 |
| 2019 | 9 | 15 |
| 2020 | 15 | 17 |
| 2021 | 10 | 9 |
| 2022 | 8 | 14 |
| 2023 | 4 | 12 |
| 2024 | 7 | 10 |
| 2025 | 11 | 15 |
| 2026 | 2 | 8 |
By publication year. Applications have been published since 2001. 2026 runs to 8 Oct.
Recent patents
- Methods and compositions for inducible extracellular membrane capture of monoclonal immunoglobulins secreted by hybridomas25 Aug 2026US 12,715,935 B2Lankenau Institute for Medical Research
- Method of generating multipotent stem cells14 Apr 2026US 12,600,950 B2Fundació Centre De Regulació GenòMica
- Developing an efficient hybridoma platform for therapeutic antibody discovery2 Dec 2025US 12,486,315 B2Genentech, Inc.
- Biomarker cereblon for diagnosing hepatocellular carcinoma, and novel monoclonal antibody specific thereto4 Nov 2025US 12,461,103 B2The Asan Foundation
- Transgenic chicken that makes antibodies with long CDR-H3S stabilized by multiple disulfide bridges and diversified by gene conversion30 Sep 2025US 12,428,471 B2Crystal Bioscience Inc.
- Antibodies with selectivity for the 4ig isoform of b7-h3 and methods of use thereof6 Aug 2026US 2026/0224701 A1Board of Regents, The University of Texas System
- Method for measuring pulmonary surfactant protein d, measurement kit, monoclonal antibody, and cell6 Aug 2026US 2026/0227394 A1Sekisui Medical Co., Ltd.
- Antibody compositions targeting non-phosphorylated alpha-synuclein aggregates23 Jul 2026US 2026/0209322 A1Hamad Bin Khalifa University
- Marker and method for detecting inflammation-related diseases25 Jun 2026US 2026/0176332 A1Beijing Mdtk Biotechnology Co., Ltd.
- Il13ra2-targeting herpes simplex virus and anti-il13ra2 antibody or antigen-binding fragment thereof11 Jun 2026US 2026/0159594 A1The University of Tokyo
Most cited
By later US patents
- Ransgenic non-human animals for producing heterologous antibodies1,941US 5,545,806 AGenPharm International, Inc. · 1996
- Transgenic non-human animals capable of producing heterologous antibodies of various isotypes1,748US 5,569,825 AGenPharm International, Inc. · 1996
- Transgenic non-human animals for producing heterologous antibodies1,604US 5,625,126 AGenPharm International, Inc. · 1997
- Transgenic non-human animals capable of producing heterologous antibodies950US 5,770,429 AGenPharm International, Inc. · 1998
- Transgenic non-human animals for producing heterologous antibodies679US 5,814,318 AGenPharm International, Inc. · 1998